Separating the 340B drug discount program into one for hospitals and another for non-hospital healthcare providers would be the wrong response to drug company denials of 340B pricing when providers use contract pharmacies, AIDS Healthcare Foundation said yesterday.
“A new program will not stop industry efforts to eliminate discounts to increase profits,” AHF General Counsel Tom Myers said in Nov. 30 news release. 340B entities instead “must continue to work together to strengthen and protect the 340B program,” AHF said.
Separating the 340B drug discount program into one for hospitals and another for non-hospital healthcare providers would be the wrong response to drug company denials of 340B pricing when providers use contract pharmacies, AIDS Healthcare Foundation said yesterday.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
